Stryker Corporation (LON: 0R2S)
London
· Delayed Price · Currency is GBP · Price in USD | Market Cap | 120.87B |
| Revenue (ttm) | 16.39B |
| Net Income (ttm) | 2.68B |
| Shares Out | n/a |
| EPS (ttm) | 6.96 |
| PE Ratio | 45.13 |
| Forward PE | n/a |
| Dividend | 2.53 (0.65%) |
| Ex-Dividend Date | Dec 31, 2024 |
| Volume | 2,282 |
| Average Volume | 689 |
| Open | 392.99 |
| Previous Close | 394.70 |
| Day's Range | 391.00 - 394.97 |
| 52-Week Range | 250.79 - 394.97 |
| Beta | 0.99 |
| RSI | 65.57 |
| Earnings Date | Jan 28, 2025 |
About Stryker
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The ... [Read more]
Financial Performance
In 2023, Stryker's revenue was $20.50 billion, an increase of 11.11% compared to the previous year's $18.45 billion. Earnings were $3.17 billion, an increase of 34.22%.
Financial numbers in USD Financial StatementsNews
Stryker Corp (SYK) Announces Cash Tender Offer for Inari Medical
Stryker Corp (SYK) Announces Cash Tender Offer for Inari Medical
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical
Stryker commences tender offer for all outstanding shares of common stock of Inari Medical, Inc.
Portage, Michigan, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK) today announced that it is commencing, through a wholly owned subsidiary, Eagle 1 Merger Sub, Inc., a cash tender offer to purc...
If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
Stryker (NYSE: SYK) has outperformed the market over the past 15 years by 2.05% on an annualized basis producing an average annual return of 13.94%. Currently, Stryker has a market capitalization of ...
How Is The Market Feeling About Stryker?
Stryker's (NYSE: SYK) short percent of float has risen 8.47% since its last report. The company recently reported that it has 4.62 million shares sold short , which is 1.28% of all regular shares tha...
Stryker Had A Good Year Last Year; Here's How It's Looking For 2025
Stryker shows rising price performance, earning an upgrade to its IBD Relative Strength Rating
Plug Power, Capri And Frontline Are Among Top Mid Cap Gainers Last Week (Jan 6-10): Are The Others In Your Portfolio?
These eleven mid-cap stocks were the best performers in the last week. Are they in your portfolio? Inari Medical, Inc. (NASDAQ: NARI) shares jumped 53.07% after Stryker Corporation (NYSE: SYK) agree...
Mixed gains/losses in the major indices
The major US indices are ending the day mixed with the Dow and S&P higher, and the Nasdaq and Russell 2000 lower. Trading conditions were up and down volatile. Tomorrow the stock markets will be close...
Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal dilution. Learn more on SYK stock here.
Stryker: Starting 2025 With A Bolt-On Deal For Inari Medical
Stryker's acquisition of Inari Medical strengthens its Neurovascular business, but its high valuation may warrant caution for investors. Learn more on SYK stock here.
INARI MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inari Medical, Inc. - NARI
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Inari Medical, I...
Stryker Acquires Inari Medical in a $4.9 Billion All-Cash Deal
Stryker Acquires Inari Medical in a $4.9 Billion All-Cash Deal
Penumbra spikes after Stryker- Inari deal
Penumbra (PEN) stock rises as Stryker (SYK) agrees to acquire its rival in the thrombectomy market, Inari Medical (NARI) for $4.9B in cash. Read more here.
Inari Medical (NARI) Surges as Stryker Announces Acquisition
Inari Medical (NARI) Surges as Stryker Announces Acquisition
Inari Medical Jumps 22% as Stryker Confirms $4.9B Acquisition Deal with 60% Premium
Inari Medical Jumps 22% as Stryker Confirms $4.9B Acquisition Deal with 60% Premium
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation (NYSE: SYK) agreed to acquire Inari Medical Inc. (NASDAQ: NARI) for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billio...
Stryker To Buy Inari Medical In $5 Billion Deal To Bolster Venous Thromboembolism Position
On Monday, Stryker Corporation SYK agreed to acquire Inari Medical Inc. NARI for $80 per share in cash, representing a total fully diluted equity value of approximately $4.9 billion.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1398853253-8c0838ae08a346ed9b154bf2bf29124e.jpg)
Inari Shares Skyrocket As Stryker Will Acquire Medical Device Maker for $4.9B
Inari Medical stock skyrocketed Monday afternoon and again Tuesday morning after a report that it was close to being acquired by Stryker proved to be true, with the companies announcing the deal after...
Stryker Corporation (SYK) Announces Merger Agreement with Inari Medical
Stryker Corporation (SYK) Announces Merger Agreement with Inari Medical
Inari Medical Inc (NARI) Under Investigation for Proposed Sale to Stryker
Inari Medical Inc (NARI) Under Investigation for Proposed Sale to Stryker
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker to Acquire Inari Medical in Deal Valued at $4.9 Billion
Inari makes mechanical thrombectomy solutions designed to treat peripheral vascular diseases. Stryker said the deal would be complementary to its neurovascular business.
Stryker Agrees to Buy Inari Medical for $80 Per Share
Medical device maker Stryker Corp. agreed to purchase Inari Medical Inc. for about $4.9 billion to expand its offerings in the fast-growing area of treating blood clots in the legs and lungs.
Stryker confirms deal to purchase Inari Medical for $80 a share
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Portage, Michigan and Irvine, California, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the ...